| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.7B | $0.6B | $0.5B | $0.3B |
| Cost of Revenue | $0.8B | $0.9B | $0.9B | $1.0B | $0.6B | — | — |
| Gross Profit | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — |
| SG&A Expense | $0.7B | $0.7B | $0.7B | $0.7B | $0.6B | $0.6B | $0.4B |
| Operating Income | $0.1B | $-0.3B | $-0.7B | $-3.9B | $0.0B | $0.0B | $-0.0B |
| Net Income | $-0.2B | $-0.6B | $-0.9B | $-4.0B | $-0.3B | $0.0B | $-0.1B |
| EPS (Basic) | $-0.30 | $-0.96 | $-1.47 | $-5.97 | $-0.20 | $-0.28 | $-0.28 |
| EPS (Diluted) | $-0.30 | $-0.96 | $-1.47 | $-6.24 | $-0.20 | $-0.25 | $-0.28 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Total Assets | $11.1B | $11.5B | $12.7B | $13.9B | $20.2B | $15.2B | $3.8B |
| Current Assets | $1.3B | $1.2B | $1.5B | $1.4B | $1.6B | $1.3B | $0.5B |
| Cash & Equivalents | $0.3B | $0.3B | $0.4B | $0.3B | $0.4B | $0.3B | $0.1B |
| Total Liabilities | $6.2B | $6.4B | $6.7B | $7.1B | $8.3B | $5.6B | $2.4B |
| Current Liabilities | $1.6B | $1.4B | $1.6B | $1.6B | $1.9B | $1.6B | $0.7B |
| Stockholders' Equity | $4.8B | $5.1B | $6.0B | $6.8B | $11.9B | $9.6B | $1.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.7B | $0.5B | $0.3B | $0.3B | $0.1B |
| Investing Cash Flow | $-0.3B | $-0.2B | $-0.2B | $0.1B | $-4.0B | $-3.0B | $-0.1B |
| Capital Expenditures | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | — |
| Financing Cash Flow | $-0.3B | $-0.5B | $-0.5B | $-0.8B | $4.0B | $2.9B | $0.1B |